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In many healthcare systems electrical stimulation of the human auditory system, 
using cochlear implants, is a common treatment for severe to profound deafness. 
This chapter will describe how electrical stimulation manages to compensate for 
sensory-neural hearing loss by bypassing the damaged cochlea. The challenges 
involved in the design and application of cochlear implants will be outlined, includ-
ing the programming of clinical systems to suit the needs of implanted patients. 
Today’s variety of patient will be reviewed: unilaterally and bilaterally implanted, 
bimodal users of a cochlear implant as well as a contralateral hearing aid, CROS 
device users having either asymmetrical hearing loss or single-sided deafness. 
Alternative devices such as auditory brainstem implants will be described, and 
additionally the more experimental auditory mid-brain implants and intraneural 
stimulation approaches. Research that is likely to bring medium term benefits to the 
clinical application of cochlear implants will also be described.
Keywords: cochlear implant, electrical, stimulation, prosthesis
1. From the beginning to current practice
Electrical stimulation of the human auditory system is generally traced back to 
the pioneering experiments of Alessandro Volta, inventor of the battery. When Volta 
applied 50 volts to his own head, he reported hearing an unpleasant boiling sound 
[1]. However, the forerunner of a modern CI system is just over 60 years old: oppor-
tunistic stimulation of the auditory nerve [2] of a bilaterally deaf patient receiving a 
facial nerve graft. During the two decades following this work, various clinical stud-
ies [3–10] saw the implantation of single and then multi-channel cochlear implant 
(CI) systems in people suffering profound deafness. While many of these pioneers 
suffered ridicule at the hands of the mainstream scientific community, clinical con-
siderations prevailed. The early devices that were produced in academic institutions 
were transferred to commercial organizations, these often building on prior medical 
device experience, for example experience gained in the pace maker field.
Today over half a million people, from babies under 6 months of age to adults in 
their late 90s, have been implanted with a CI. While it can be argued that the CI is the 
most successful medical device ever created, the outcomes are still highly variable 
(Figure 1). In the best of cases, CI users can make fluent use of a telephone, understand 
speech in adverse listening conditions where there is considerable competing noise 
and reverberation, hence enjoying independence spanning social lives and careers that 
would have been unimaginable without their CI device. Even where speech understand-
ing is limited, a release from the isolation of deafness through access to environmental 
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sounds, a reduction in the level of tinnitus and support of lip-reading with a reduction 
in the effort required for oral communication are all worthwhile benefits from use of a 
CI. It should also be noted that in many cases those most satisfied with their implant are 
not those who receive the highest scores on standardized tests of speech understanding.
The following sections will describe how electrical stimulation of the auditory 
system is achieved, with the main focus being on CI systems. The factors that influ-
ence outcome, so far as they are known, will be described, along with the challenges 
in delivering clinical service, both today and into the future. With the future in 
mind the major research topics that are currently being addressed will be outlined.
2. Overview of a cochlear implant system
Figure 2 shows the various components common to all of today’s clinically applied 
cochlear implant systems. Sound is typically collected from microphones housed on a 
behind the ear (BTE) sound processor. The sound is first “cleaned” to remove noise and 
then processed to create the stimulation patterns destined for the implanted electrode 
array. Except in the case of one-piece processors, a lead connects the sound processor 
output to a radio frequency (RF) transmitter coil located above and behind the ear. The 
external coil is held in place over the implant’s receiver coil through a pair of magnets: 
one external and one within the surgically implanted device under the skin. This 
arrangement supports reliable communication across the skin through the use of RF 
based telemetry. The RF signal provides both power for the implant’s electronics and 
the information needed to produce electrical stimulation. Hence the implant consists 
of: its receiver coil, a hermetic package containing electronic circuits and an electrode lead 
assembly connecting to the electrode array that is placed inside the cochlea (Figure 3).  
In some of today’s CI systems the sound processor and RF coil are a single component 
held in place by the magnet but having no wire or BTE part. This provides some esthetic 
advantage but may fall off more easily and compromises sound collection.
Additionally today’s implants have the ability to make both physical and physiolog-
ical measurements, using back-telemetry, to transmit these data to the sound proces-
sor. Through the use of wireless technology, information can be relayed to and from a 
host of devices: smartphones, tablets, laptops, remote microphones or other listening 
aids. Such connectivity leaves a CI user well placed to use many consumer devices to 
enhance their communication and support maintenance of their implant system.
Figure 1. 
Percent correct scores on the CNC word test ranked from poorest to best for 113 cochlear implant users showing a 
large variation in outcome reproduced from Holden et al. [79].
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3. Electrical stimulation principles
In the earlier chapters of this book the auditory system has been described in 
some detail, including pathology that can result in the most debilitating degrees of 
hearing loss: severe to profound deafness. Fortunately, electrical stimulation can 
be delivered without external, middle or indeed even an inner ear. However, in the 
Figure 2. 
The components of a behind the ear (BTE) model of cochlear implant showing (1) the T-mic placed in the 
external ear canal, (2) BTE sound processor, (3) radio frequency transmitting headpiece, (4) the implant body, 
(5) intra-cochlear electrode array and (6) the auditory nerve.
Figure 3. 
A cross-section through the spirally-shaped cochlea showing the various compartments, including the scala 
tympani with a mid-scala located electrode array.
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large majority of clinical cases the auditory nerve is intact and can be accessed via a 
very poorly or non-functioning cochlea: it being this damage that the CI bypasses. 
The operating principle of a CI is that small electrical currents are able to initi-
ate activity on the auditory nerve that crudely mimics the activity produced by a 
normally functioning cochlea. Taking advantage of the cochlea’s tonotopic organi-
zation, currents representing high frequency sounds are delivered to the base, while 
currents representing lower frequency sounds are delivered to more apical cochlear 
locations. This is achieved through the use of an electrode array containing multiple 
separate electrode contacts placed along the scala tympani (Figure 4). The number 
of intra-cochlear electrode contacts in clinical service varies by manufacturer 
between 12 and 24. In addition, either the shorting of adjacent contacts, or simulta-
neous delivery of synchronized stimulation patterns on multiple electrode contacts, 
seeks to increase the number of stimulation sites available [11–13].
In Figure 4 an electrode array is shown placed in the scala tympani. Here the 
exposed electrode surface, from which stimulation current is delivered, faces 
towards the modiolar wall, behind which the auditory nerve’s spiral ganglion cell 
bodies are located in Rosenthal’s canal. The remainder of the array is composed of 
a soft silicone that supports the contacts and the insulated wires connecting the 
electrode contacts to the implant’s electronics. A modiolar facing contact surface 
orients the electrical stimulation towards the primary stimulation targets, the spiral 
ganglion cell bodies. Since the perilymph fluid in the scala tympani is electrically 
conductive, it allows current to flow through the cochlea and achieve stimulation 
of neural elements. A downside is that current also tends to spread along the scala, 
rather than addressing only the area local to the electrode contact where we would 
like it to act. If peripheral processes still remain in the cochlea, extending from the 
cell bodies to the organ of Corti, then these may also be targets for electrical stimu-
lation. Unfortunately it is not currently possible to accurately know the status of any 
individual’s cochlea. It appears reasonable to assume that a great deal of the vari-
ability illustrated in Figure 1 comes from variations in the health of those individu-
als’ cochleae, this variation being part dependent on environment and disease and 
the individual’s particular physiology, as well as how any one individual’s immune 
system reacts to the insertion and presence of the electrode array itself.
The most common type of stimulation paradigm used in CIs today is monopolar 
stimulation (Figure 5a). Here the implant introduces current into the cochlea via 
a relatively small electrode contact. A typical surface area might be 0.2 mm2. The 
density of current close to the electrode contact introduces a higher probability of 
activating elements close to the contact, the probability decreasing for elements 
Figure 4. 
View of how an electrode array will be positioned within the scala tympani of the cochlea, here with the 
electrode contacts facing towards the modiolar wall behind with the spiral ganglion cell bodies are located.
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at increasing distance. Monopolar stimulation current is returned to the implant 
using a distant extra-cochlear electrode that has at least 10 times the intra-cochlear 
electrode contact’s surface area. This keeps the returning current density low, 
avoiding stimulation at this remote site. Typically there are two return electrodes 
on a cochlear implant, in case anything goes wrong with one of them. One is placed 
on the body of the implant while the other is on a separate flying lead, or on the 
electrode lead assembly but located outside of the cochlea. In Figure 6 an implant 
can be seen with its various component parts indicated.
Alternative stimulation paradigms are sometimes used, but mainly for research. 
Figure 5b shows a bipolar stimulation paradigm. Here two intra-cochlear electrode 
contacts, separated by around 1 mm, operate as a pair. Stimulation is introduced by 
one contact and returned by the other. This in theory restricts stimulation to a small 
part of the cochlea, so should help with the spread of current mentioned above. 
However, in practice current introduced by one contact is returned to the other 
without activating enough neural tissue to create a loud enough hearing sensation. 
Hence, it is often necessary to form a bipolar pair using contacts that are not adja-
cent but for example are spaced 2 mm or more apart. In addition, the arrangement 
of contacts along the cochlea means that there will be a plane of zero field between 
the contacts, leading to a need to use higher currents and thus produce a wider 
spread in stimulation. In Figure 5c tripolar stimulation is shown. Now a group of 
three electrode contacts are used together. Stimulation is introduced via the middle 
contact and ideally half returned via the adjacent contact on either side. This avoids 
Figure 5. 
Electrical stimulation configurations: (a) monopolar where current is returned to a large distant extra-cochlear 
return electrode, (b) bipolar where current flows between adjacent intra-cochlear electrodes and (c) tripolar 
where current is returned by two adjacent contacts.
Figure 6. 
A cochlear implant showing its various components. Note the two ground or return contacts, one on the case 
body and one on the electrode lead assembly.
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the zero potential plane problem of bipolar stimulation and theoretically provides 
a tighter containment of stimulation. Again, in practice there is a need to recruit a 
given number of neurones to signal sufficient loudness and this means increasing 
the tripolar stimulation current on the middle contact. Eventually the current on 
the return electrodes will become high enough to cause stimulation, resulting in 
a wider spread of current than intended. In many cases it is not even possible to 
increase the current far enough to achieve sufficient loudness for a tripolar configu-
ration. In such cases some of the current has to be returned to the remote extra-
cochlear return electrode, a configuration referred to a partial tripolar. This even 
further increases the current spread. So, with these practical limitations in mind it 
is not difficult to see why monopolar is universally used as the default stimulation 
paradigm, despite the apparent large current spread that this entails.
3.1 Technical considerations
In the interests of simplicity some of the more technical aspects of electrical 
stimulation have been avoided in the text above, allowing focus on the broader 
application. In this section some of these more technical issues will be discussed. 
Where a reader is not interested in technical detail this section can be ignored.
Ohm’s Law states that the electrical voltage difference required to drive a given 
current is directly proportional to the resistance through which the current has to 
flow. With changes in the resistance, or more generally the impedance if we con-
sider frequency effects, a voltage source would lead to uncontrolled changes in the 
current being output. As described below this could lead to uncontrolled changes in 
loudness over time. Most of today’s CI systems deliver electrical stimulation through 
one or more current sources. As the name implies, this circuit attempts to deliver 
the current requested of it regardless of how much electrical resistance is offered 
by the body. A current source is said to be in compliance when it is delivering the 
current requested of it. Given a finite amount of voltage being available within an 
implant, for example 8 volts, there will be a maximum impedance into which the 
implant’s maximum output current can be delivered. With a typical stated maxi-
mum output current of 2000 μA, the maximum impedance for which this could be 
delivered will be 4000 Ohms (8 volts divided by 2000 μA, or 8/2 × 10−3 = 4000). 
For higher impedances the maximum stated output current will not be available. 
For lower impedances the implant will be limited to its maximum output current 
value, ensuring safe operation.
Since CI systems are designed to provide stimulation for essentially all waking 
hours, day after day over decades, their output must not damage the neural tissue 
that they are intended to stimulate. One obvious source of damage is the delivery 
of direct current (DC). If a DC current is applied to the body it will result a process 
called electrolysis. Here there will be a continuous transport of ions, charged atomic 
particles, leading to dissolution of the platinum electrode contact and destruction 
of the cochlear tissue: obviously a catastrophic situation. Research in animals indi-
cates that even very small amounts of DC, 400 nA, is enough to cause tissue damage 
[14]. Several mechanisms are used in a CI to prevent the delivery of DC. Firstly, a 
balanced stimulus waveform is used, almost always a symmetrical pulse having two 
complementary phases (Figure 7a), although so long as the two phases contain an 
equal and opposite area they need not be symmetrical (Figure 7b). At the simplest 
interpretation, the first phase, referred to as cathodic, will depolarize neurones 
hence producing the electrical stimulation that we seek to achieve. The second, 
anodic, phase balances the stimulation resulting in no nett current being delivered 
to the body, thereby avoiding DC. Even with very careful design, there is likely to 
be some small imbalance between the two phases. To account for any in-balance, 
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following delivery of a stimulation pulse the electrode contact is connected to 
ground, ideally removing any residual DC. Finally, an electronic component called a 
capacitor is placed in series with the stimulating electrode contact. A capacitor does 
not allow DC to pass, so offers yet more protection in case some fault in the elec-
tronics interferes with either of the previous two protection mechanisms. Together 
these mechanisms appear successful in avoiding the delivery of DC. Devices do fail, 
particularly in the pediatric population, with reimplantation rates over tens of years 
being reported at 8% from the well-established Sydney clinic [15]. Typically half of 
these failures are medical issues and half device failures. However, in virtually all 
cases it is possible to re-implant the patient, with outcomes almost always being as 
good as those obtained when the original device was working well [16].
While we speak about stimulation current it is really the electrical charge that 
is at issue. Charge is simply the product of current times time and has units of 
Coulombs, C. Electro-chemical considerations mean that an electrode has a maxi-
mum charge injection capacity, such that a given size and material will only be able 
to handle a given charge limit in a reversible way, so that all of the charge injected 
in one phase can be removed in the second phase [17]. This is necessary to avoid the 
DC as discussed above. A conservative value for the maximum charge density, typi-
cally 30 μC/cm2 [18], taking account of the electrode dimensions, is programmed 
into the implant’s controlling software, ensuring that this limit is never exceeded. 
Animal experiments confirm that chronic stimulation with higher charge densities, 
for example 400 μC/cm2, results in the dissolution of platinum but interestingly not 
to the loss of auditory neurones [19]. The loudness sensation produced by electri-
cal stimulation is related to the amount of charge delivered in one phase of the 
stimulation waveform. There is also an effect of the rate at which stimulation pulses 
are delivered. However, for the stimulation rates used in clinical practice, typically 
500–2000 pulses per second per channel (ppps/ch) the effect of rate is quite small 
and largely ignored.
Stimulation current flows through cochlear tissue as a result of voltage dif-
ferences developed along the current’s path. How these voltage differences are 
arranged along the length of a neurone’s peripheral or medial process, or indeed 
across the cell body, determines which neurones depolarize, leading to action 
potentials being generated. The action potential may propagate to the medial 
synapse with the cochlear nucleus and hence initiate activity on the auditory 
pathway, leading to a sense of hearing being detected in the brain. Rather than 
stimulating a single neuron, typically hundreds, or even thousands, of neurones in a 
region of the cochlea will be addressed by a single electrode contact. These patterns 
Figure 7. 
Stimulation waveforms with balanced cathodic and anodic phases may have either symmetrical phases (a),  
or asymmetrical phases (b) where the area of each phases is identical.
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of stimulation are interpreted as sound input by the higher levels of the auditory 
system, leading to the sense of electrical hearing. The next section will describe 
how sounds detected by the CI system’s microphone will result in the generation of 
electrical stimulation patterns.
4. Operation of the cochlear implant system
The main cochlear implant system functions are shown schematically in Figure 8. 
Sound from the microphone is compressed by a single-channel automatic gain 
control (AGC) system. Compression ratios in CI systems tend to be substantially 
higher than those in acoustic hearing instruments: six to infinity, compared to two 
to three respectively. This reflects both the small electrical dynamic range of typi-
cally 10 dB [20] and the exponential like increase in loudness found for electrical 
hearing [21]. Both considerations require tight control of the stimulation current’s 
amplitude to avoid discomfort. Research with different implant types shows a 
consistent advantage for slow-acting AGC, the benefit being a reduced compression 
of the information rich temporal modulations of speech [22–24], as well as a reduced 
co-modulation effect [25] associated with the single channel AGC.
Following AGC, the sound is broken into a number of frequency channels, 
this number varying between 12 and 24 channels, reflecting the number of 
intra-cochlear electrode contacts available in the implant model. In Figure 8 only 
four channels are used to illustrate the principle. Today a Fast Fourier Transform 
(FFT) algorithm is often used to separate the incoming sound into discrete 
frequency channels. The amount of energy in each channel is then estimated by a 
rectification and low-pass filtering process. While the average energy is calculated 
over a period of perhaps 10 ms (milliseconds) or more, stimulation pulses will be 
delivered much more rapidly, typically once every millisecond. Hence calculations 
will be made that overlap in time in an attempt to follow the changes in speech 
energy over time. Next the acoustic energy in each channel is mapped to an elec-
trical current amplitude that takes account of the CI user’s sensitivity to electrical 
stimulation. The goal is to use smaller currents that barely produce a perception 
of electrical stimulation to represent low-intensity acoustic activity and larger 
currents that are perceived as loud to represent very intense acoustic events. This 
Figure 8. 
A schematic of the sound processor system where sound is collected by the microphone, compressed by an 
automatic gain control, broken into discrete frequency channels, which have their energy assessed and mapped 
to the user’s requirements. This information is then combined into a digital stream, transmitted by radio 
frequency to the implant where stimulation currents are generated.
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needs to be managed separately for each channel, resulting in the continuous 
output of a stream of stimulation amplitudes for each channel. As shown sche-
matically, these amplitudes are then combined together for transmission by the 
RF signal across the skin to the implant. Electronics inside the implant extract the 
digitally transmitted amplitudes, convert them to analogue values and then drive 
the implant’s current source(s), resulting in stimulating currents being deliv-
ered by the intra-cochlear electrode contacts. For virtually all of today’s clinical 
systems only one channel will be stimulated at a time. This approach avoids the 
channel interactions that would occur were channels presented simultaneously 
within the conductive scala tympani [26]. The disadvantage of this approach can 
be seen in Figure 9 where a channel is only updated during its own time period, 
therefore, must wait until all the other channels have been updated until new 
information can be transmitted. Deliberately, very brief current pulses each of 
around 40–50 μs duration (20–25 μs/phase) are used, so that it is still possible 
to update each channel rapidly enough to keep up with the changes in acoustic 
energy over time. This often means stimulation at more than 1000 pps/ch. Such 
an approach generally leads to higher levels of speech understanding than where 
simultaneous stimulation is delivered [27, 28].
4.1 Sound coding strategies
Over the years the sound coding strategy, a software algorithm that relates audio 
from the sound processor microphones to the electrical patterns appearing at the elec-
trode contacts, has changed. Initially it was believed that the damaged auditory system 
was not capable of transmitting much information, hence the most useful information 
was extracted from the speech and directly coded on sets of electrodes. For example 
an early feature extraction strategy F0F1F2 [29] extracted the first two formants of 
speech, F1 and F2, from which it is possible to estimate the vowel being articulated. 
Each formant range had a set of electrode contacts allocated, such that higher or lower 
frequencies for each formant lead to stimulation on more basal or more apical elec-
trode contacts in that formant’s electrode set. The rate at which pulses were delivered 
was related to the fundamental frequency (Fo) driving the vocal tract, leading to the 
Figure 9. 
An illustration of now non-simultaneous waveforms delivers information for each channel. Once a channel has 
been stimulated no more information may be delivered until the other channels have been updated.
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strategies name. Such a strategy supported only very modest levels of speech under-
standing, around 8% correct for monosyllabic words presented in quiet [30]. The 
information extracted was limited to begin with and further reduced through errors 
generated in real life listening situations where background noise, reverberation and 
intensity and frequency response variations led to the algorithm making mistakes in 
both the extraction of formant frequencies and in the estimation of Fo.
It was eventually recognized that the brain was better at extracting informa-
tion than the feature extraction algorithms and hence “whole-speech strategies” 
replaced feature extraction. Today’s sound coding strategies simply average the 
energy in each channel’s frequency range and generate levels of stimulation that 
represent this. In some cases a so-called n-or-m strategy will work out which subset 
(n) channels from the total (m) number available have the highest energy and then 
only stimulate this reduced set. Refinements to this may neglect adjacent channels 
on the basis that stimulating both will not add anything, so select a more distant 
lower amplitude electrode to transmit more information [31].
4.2 Neural population
Stimulation delivered by a CI system will result in the depolarization of neural ele-
ments, resulting in action potentials being generated that propagate to the next stage of 
the auditory system: the cochlear nucleus. With reference to the schematic of Figure 8,  
there is a population of spiral ganglion neurones associated with each electrode and 
hence each frequency channel of the CI system. As mentioned above, a channel’s stimu-
lation current will need to recruit a certain population of neurones whose firing indi-
cates to the brain the amount of activity in a particular frequency range. Ideally, there 
will be a sufficient local neural population such that progressively increasing stimulation 
current initiates an appropriate number of action potentials, so that the brain correctly 
perceives the amount of acoustic activity in the channel’s frequency range.
Unfortunately a discrete neural population for each channel as shown in 
Figure 10a is not always available. In Figure 10b only a reduced neural population 
is available for each channel. Hence, when there is a lot of activity in one channel, 
requiring recruitment of a full population of neurones, these are not available 
locally. It is still possible to increase the stimulation current, spread the electrical 
field further away from the electrode and depolarize neurones that should really be 
associated with another channel. While this will satisfy the perception of loudness, 
it generates channel interaction so that we are no longer able to deliver frequency 
specific information to a discrete part of the cochlea. The perception will be of a 
blurred or fuzzy sound, particularly a problem when trying to listen to speech in the 
presence of competing noise.
An alternative situation is shown in Figure 10c where most electrodes have a 
sufficient local neural population but one electrode is located in a so-called dead 
region [32]. When electrode 2 is stimulated it can only recruit neurones from the 
population belonging to electrodes either side of it, delivering information about 
channel 2’s frequency region to other parts of the cochlea, spreading stimulation 
widely and interfering with the otherwise discrete frequency information being 
delivered by the neighboring channels.
Unfortunately, it is not currently possible to determine what the number and 
distribution of neural elements is for any individual. The literature is not always 
helpful in this area. As shown in Figure 1, there is great variability in outcome for 
the identification of monosyllabic words. Since this task involves little top-down 
processing, much of the variability in outcome must come from the electro-neural 
interface. Beyond speech understanding, examining the ability to discriminate 
adjacent electrodes, or intra-electrode stimulation sites [33], also showed both 
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great variability between subjects and across the electrode array of individual 
subjects. This task, having no confound with cognitive processes related to speech 
understanding, further confirms the presence of peripheral variability and its likely 
contribution to variations in outcome.
It is unclear to what degree a loss of spiral ganglion cells (SGC) in humans will 
follow, even after years of severe to profound deafness. Histological studies of 
humans who had used a cochlear implant sometimes show a reasonable correla-
tion between CNC word score and SGC count: for example R = 0.62 [34], R = 0.9 
[35] but for a small group of only 6. However, the variability is such that the same 
SGC count can show variations of between 30% and 75% for CNC words, or the 
same CNC word score can be associated with 3000 or 18,000 SGCs. Examining the 
threshold current for detecting electrical stimulation in a group of 130 lateral wall 
electrode array users [36] showed significant differences between four groups: the 
increase in group mean threshold being associated with a reduction in monosyllabic 
word score. This works suggests that a higher SGC population (lower electrical 
threshold) is associated with better speech understanding.
The literature listed above indicates that there is a relationship between the 
number of spiral ganglion cells and the ability to identify monosyllabic words when 
using a cochlear implant. Contributions to speech understanding may also come 
from a large number of additional factors, some of which include: the distribution 
of SGCs, angular insertion of the electrode array, distance of the electrode contacts 
from the modiolar wall, presence or absence of peripheral processes, fibrous sheath 
formation and intrusion of new bone into the cochlea. How well a given implant 
user has had the parameters of their sound processor set, commonly referred to as 
their program, is another variable that we will examine next.
4.3 Programming the cochlear implant
As has been explained above, the small electrical dynamic range available to a 
CI user makes it necessary to carefully adjust the stimulation parameters to suit the 
Figure 10. 
A schematic representation of three different neural populations: (a) a full population exists for each channel, 
(b) a depleted population results in channel interaction and (c) a dead region requires recruitment from the 
populations rightly belonging to adjacent channels.
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requirements of each individual recipient. The most important adjustment is the 
amount of stimulation that will be delivered in response to acoustic activity. This 
must be done for each of the CI’s separate channels. Each channel has two primary 
parameters that control its output. One will be typically called a most comfortable 
level, shortened to either M-Level or C-Level. The other is a threshold control, 
referred to as T-Level. The main CI manufacturers use these parameters slightly 
differently but to a good approximation T-Level sets the minimum stimulation 
level that the implant will deliver and M-Level will set the maximum stimulation 
level that can be delivered for an individual recipient. The sound processor will 
then arrange for the amount of acoustic range that it handles, somewhere between 
40 and 80 dB depending on the user’s setting and implant model, to be mapped 
to stimulation levels between T- and M-Level. In combination with the AGC of 
the system this will give the CI user access to their acoustic environment such that 
hearing levels of between 20 and 30 dB HL are achieved across the frequency range 
250–8000 Hz. The combination of AGC and M-Level ensures that even high inten-
sity sounds of 100 dB SPL do not produce uncomfortably loud sensations. Unlike 
acoustic hearing, it is generally possible to provide CI users with access to the full 
range of frequencies that are most important for speech understanding.
Which channels are activated is another important adjustment to make. Most 
audiologists are reluctant to deactivate channels, although sometimes a reduced set 
of channels can give a better outcome. In some cases an electrode array is not fully 
inserted into the cochlea, perhaps due to the cochlea being too small, or there being 
fibrosis tissue, or bone, that prevents a full insertion being obtained. Alternatively, 
electrode arrays can sometimes extrude from the cochlea [37, 38], either shortly 
after implantation or months to years later. In all these cases the more basal elec-
trode contacts will need to be deactivated. Deleting electrodes from a program 
will lead to the frequency range being remapped across the remaining electrode 
contacts. There will be a coarser representation of frequency since fewer channels 
are now available. However, removing electrodes that are not inside the cochlea will 
produce a better outcome than simply leaving these electrodes active.
Beyond setting T- and M-Levels and defining an appropriate set of electrode 
contacts, there is sometimes adjustment made to the acoustic dynamic range 
mapped by the sound processor. This effectively controls the compression of 
acoustic sounds into the electrical dynamic range. It might seem logical to use as 
large an acoustic or input dynamic range (IDR) as possible, since this will maxi-
mize the range of sounds available to a CI user. However, it is the discrimination of 
different levels of sound in each channel that carries information. An excessively 
large IDR may squeeze these amplitude cues, reducing the ability of an implant 
recipient to understand speech. There are many parameters that can be adjusted 
in a CI system. However, it is common for the majority to remain at their default 
values. This may be through an inability to obtain user feedback, for example in 
young children, lack of time or knowledge on the part of the clinician, or a recom-
mendation from the CI manufacturer.
How appropriate values are found for the T- and M-levels depends very much 
on the individual CI user. For a post-lingually deafened adult it is reasonably 
straightforward to find these. By presenting 200 ms bursts of stimulation and using 
a standard bracketing approach, the smallest detectable amount of stimulation 
for each channel can be found and this value set as the T-level. Similarly, progres-
sively increasing the stimulation will allow an M-level to be found, the CI user 
often pointing to different categories on a loudness chart as the various levels of 
stimulation are presented. These measures can be made for each individual channel, 
channels can be programmed in groups of four, or only five or six channels across 
the electrode array measured with intermediate channels set to interpolated values.
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For babies or young children and even for some adults, objective measures are 
often used to help set program levels. The most common measure used is the eCAP, 
the electrically elicited compound action potential [39]. The ability to record eCAPs 
is built into the fitting systems for all of today’s major CI systems. Here masker-
probe or alternate-subtraction techniques [40, 41] are used to reduce the large 
stimulus artifact. The amplitude of the remaining physiological signal, arising from 
synchronized activity on the auditory nerve, is then graphed against the stimulation 
level. A regression line extrapolates to intersect the stimulation axis which would 
correspond to a zero amplitude of eCAP. The stimulation value for which this occurs 
is then used as a guide for setting programming levels. Avoiding stimulus artifact 
and allowing sufficient neural synchronization, means that much lower stimula-
tion rates are used when measuring eCAPs than for actual everyday stimulation. 
The means that the absolute eCAP values can fall at various parts of an individual’s 
electrical range. Fortunately, it is the profile of values across the electrode array that 
it is important to determine. Once this is estimated a global change in level can be 
made to obtain appropriate loudness. In many cases the T-levels are set to 10% of the 
M-level since this is almost certainly not going to leave them set too high. Typically 
T-levels are measured at something like 25% of M-level [42]. When they can be 
measured and hence individually set, T-levels will tend to improve access to low 
intensity sounds. Often in clinical practice T-levels are set at a percentage of M-level 
even where they could be individually set: the additional benefit not being consid-
ered worth the additional effort needed for measurement.
Other objective measures are used to assist with programming, although less 
often due to these requiring additional equipment to be used in collaboration with 
the CI fitting system. There is a reasonable correlation between an electrically 
elicited stapedius reflex threshold (eSRT) and M-level [43]. Unlike eCAPs here the 
same stimulation rate can be used to measure eSRT as will be used in the everyday 
program. This simplifies the setting of levels and is partly behind why there is such a 
good correlation with M-level. Less commonly the electrically elicited auditory brain-
stem response (eABR) is used [44]. Again, eABR will require a lower stimulation rate 
to be used, so that the characteristic waveforms can be seen in up to 5 or 6 ms follow-
ing stimulation. This tends to produce an extrapolated threshold for eABR quite high 
in an individual’s electrical dynamic range. As with the eCAP and eSRT measures, it 
is the relative levels across channels that are important, the profile then being globally 
adjusted to determine the M-levels that will be used in the program.
Less frequently, some statistically based approaches are used for programming. 
Simple so-called “flat maps” are used where the T- and M-level is the same on each 
channel. These are justified by the spread of monopolar stimulation recruiting 
neurones form a larger section of the cochlea than associated with an individual 
electrode contact thus tending to produce a spatial averaging. Other approaches 
might use a template based on the statistical average of levels previously measured 
for earlier CI recipients. Approaches such as FOX [45] extend this technique, 
recommending a sequence of programs with progressively increasing levels that are 
used from the very beginning. For many CI users these techniques can work quite 
well, although numbers of outliers will require individually tailored programs to 
realize their potential outcome with comfortable stimulation and reasonable access 
to their acoustic environment.
Plasticity in the auditory system means that over time the M-levels will usually 
increase. The longer term M-levels might be typically double those that can be 
tolerated during the initial fitting. After the first 2 months of device use, neither 
T- or M-levels tend to change significantly over time [46]. Change in levels is highly 
individual requiring the initial program levels to be revised numbers of times dur-
ing the first few months of implant use. Where a second (or third) fitting session is 
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planned within around 2 weeks of the first fitting, most of the change can already 
be accommodated. Looking across large numbers of adult CI users, program levels 
will be stable by between 3 and 9 months following first fitting. Individual practice 
can result in pediatric levels being more slowly increased, leading to 6–12 months 
being needed to see stable levels.
5. Different patient groups
Cochlear implants were originally designed to help those suffering bilateral 
profound deafness who could not benefit from acoustic hearing aids. Traditionally 
candidacy would have required a loss of at least 90 dB HL across all of the audio-
metric frequencies from 125 to 8000 Hz. Over the past 30 years we have seen, 
improvements in outcome (speech understanding) through better sound coding 
strategies and electrode arrays, improvements in esthetics as the external equip-
ment has moved from body worn to behind the ear or single piece processors, 
improvements in surgery with a skin to skin operating times of well under 1 hour, as 
well as much smaller incisions not requiring hair shaving and at least in some cases, 
the preservation of residual hearing. These developments have meant that a CI 
can now be considered for much more than the 0.2% of the population who suffer 
profound bilateral sensorineural deafness [47].
It is becoming more common for ears with useful low-frequency residual 
hearing to receive a CI. Candidacy can now include those with severe to profound 
levels of hearing loss above 1000–2000 Hz, but normal to moderate hearing loss 
for lower frequencies [48–50]: a group sometimes referred to as suffering partial 
deafness. Where the residual hearing can be preserved to within 10–20 dB of the 
pre-operative levels, many of these recipients use a combination of electrical and 
acoustic stimulation (EAS) in the same ear. Most CI manufacturers now make EAS 
processors so that a single instrument supports both modalities, offering comfort, 
convenience and allowing an EAS fitting to be made using a single piece of software.
Where there is some asymmetry in hearing, recent practice has seen only the 
poorer ear being implanted, while an acoustic hearing instrument is fitted to the con-
tralateral ear. This is often referred to as bimodal hearing. Dedicated hearing instru-
ments (HI) have been developed that match the compression characteristics and 
sound cleaning operations between the CI and HI, as well as offering wireless sharing 
of microphone and control signals. Such systems offer convenience for the user and 
can combine the natural acoustic low-frequency sound in the HI ear, with the high 
frequency information supporting speech understanding in the implanted ear.
Bilateral CI provision is now the standard of care in many healthcare systems, 
at least for children. Receiving two implants, either simultaneously or within a few 
months of each other, provides the best chance for the brain to have both sides work 
together. Redundancy, the countering of head shadow and a fuller sense of hearing 
are all advantages of bilateral implantation. It tends to be only considerations of cost 
that prevent bilateral CIs being offered universally to all those who could benefit 
from them. Again with wireless technology developing rapidly, the use of algo-
rithms that combine microphones between the two CI sound processors can offer 
large improvements for listening in noise when beam formers are used to attenuate 
noise coming from directions other than directly ahead, particularly useful then the 
CI user is in a one-to-one conversation in a noisy location.
Where a second CI is not available and there is no aidable hearing on the contra-
lateral ear a CROS, or strictly bi-CROS device can be used. Wireless CROS devices 
are available that essentially have their microphone pick up sound from the non-
implanted side and wirelessly route it to the CI processor on the other side where it 
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is mixed with the CI processor’s microphone signal. This approach can reduce head 
shadow, although with stimulation only being delivered to one ear there is little 
ability to use the CROS device for localization. With the combination of HI and CI 
companies, for example Phonak and Advanced Bionics within the Sonova company, 
the migration of HI technology such as the ear-to-ear wireless technology has begun 
and will likely be more common in future.
In the German healthcare system, a CI is now available to those who suffer from 
single-sided deafness (SSD). Typically there may be also be some hearing loss on 
the better hearing side, making this a highly asymmetrical loss rather than a pure 
SSD. Those suffering with SSD would usually explore a CROS device and a bone 
conduction hearing aid before considering a CI. In the end around one third of SSD 
cases seen will elect to get used to hearing with only one ear, one third will use a 
bone conduction device and one third will receive a CI [51].
Tinnitus is another consideration that can influence treatment options, for SSD 
and beyond. Where the SSD is accompanied by intractable levels of tinnitus, a CI 
may provide relief [52]. The restoration of some input to the deafened ear can allow 
the tinnitus to either effectively disappear or at least be substantially reduced. In 
some cases, SSD in particular, the relief from tinnitus is found to be of much greater 
benefit than any hearing sensation arising from the implanted ear. The large major-
ity of CI recipients report reduced amounts of tinnitus although in very rare cases 
tinnitus can be worsened through implantation.
5.1 Alternative stimulation sites
The cochlea is an attractive site for electrical stimulation, given that it presents 
tonotopic access to auditory nerve fibers with reasonably straightforward surgical 
access. However, where the cochlea has not formed properly or at all, due to some 
extreme malformation, a properly formed cochlea has been filled with bone or tis-
sue, for example following bacterial meningitis, preventing all but minimal surgi-
cal access, or the auditory nerve is not available, either through malformation or 
following trauma, stimulation of the auditory system via the cochlea is not possible. 
In such cases alternative sites of stimulation may be used.
Auditory brainstem implants (ABIs) bypass the auditory nerve, targeting the 
next station of the auditory pathway: the cochlear nucleus located in the brain-
stem [53]. There is a tonotopic structure within the cochlear nucleus, although it 
is organized in the dimension of depth, so is not easy to access. Attempts to use a 
penetrating electrode array with a number of discrete needles has not been able 
to make better use of this tonotopic organization than a pad of flat electrodes 
placed on the surface of the cochlear nucleus [54]. Programming of an ABI 
device tends to be more difficult than that of a CI. Bone surrounding the cochlea 
usually keeps the CI’s stimulation contained to auditory fibers. Only occasionally 
non-auditory stimulation of, for example, the facial nerve can be seen in muscle 
twitching around the mouth or eye. This is generally programmed around by 
deactivating electrode contacts or reducing stimulation levels. However, in the 
brain stem, functions such as respiration can be adversely effected by an ABI 
device. This calls for much more care when programming, leading to ABI devices 
being offered only by specialist centers. The surgery required to place an ABI is 
more invasive than that required for a CI, for example, requiring lifting of the 
cerebellum to gain sufficient surgical access. With ABIs being placed follow-
ing removal of tumors there can be some distortion of brain structures. Some 
surgeons prefer to remove what are often sizable tumors, allow the brainstem 
and brain structures to settle into place again and then perform a second surgery 
during which the ABI is put into place. This two-stage approach is believed to 
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provide less chance of the ABI’s electrode pad moving out of position, risking 
substantial non-auditory stimulation. Outcomes with ABI devices are generally 
substantially poorer than with CIs. In some series there is essentially no open-set 
speech understanding possible [55], while in others the speech understanding is 
limited, with only occasional high levels of speech understanding [56]. The rea-
sons for poor performance with ABIs are not fully understood. Beyond potential 
movements of the electrode pad, there are specialized auditory functions being 
carried out in the cochlear nucleus, meaning that simply assuming raw tonotopic 
stimulation patterns may not be sufficient. Additionally, those receiving ABI 
devices may have many other issues beyond deafness and these could also explain 
some of the difference in outcome.
Stimulation of even higher structures in the auditory system has been attempted 
through an auditory mid-brain implant (AMBI), where the electrode array is 
inserted into the inferior colliculus. Currently this is restricted to a pure research 
device [57]. Within the inferior colliculus it is possible to access a tonotopic organi-
zation, using a shortened version of a traditional CI electrode array, 10 mm long as 
opposed to 20–30 mm for most CI arrays. However, when accessing the auditory sys-
tem at an even higher level than with an ABI device, the amount of pre-processing 
that should have already been done leaves a crude CI type coding strategy only able 
to support very limited outcomes. Already at this level higher stimulation rates are 
inappropriate, leaving limited sound coding strategy options [58].
While placement of an electrode array in the scala tympani, or where necessary 
in the scala vestibuli, leaves the electrode contacts quite close to their target neu-
rones they are still some 1–3 mm away. This separation prevents discrete stimula-
tion of local neural populations as discussed above. It has been proposed that an 
electrode array could be inserted directly into the auditory nerve, or failing this 
inside the modiolus. Promising results have been shown from acute experiments in 
cats [59]. Recording form electrodes placed in the inferior colliculus indicates that 
intra-neural simulation is more localized than stimulation using an electrode array 
placed in the scala tympani. There are considerable challenges to overcome before 
intra-neural stimulation could be considered for humans. The surgical access is 
not straightforward, risking losing all residual hearing. The human auditory nerve 
being in the order of 1 mm diameter would require very small stimulating contacts. 
While the stimulation currents required would be smaller than those needed for a 
traditional CI, charge density considerations require careful consideration. Also, 
how well an electrode array can be placed and be tolerated in the auditory nerve, 
without the destruction of auditory fibers or the formation of granulation tissue 
will need to be carefully studied. Finally, the structure of the auditory nerve is 
complex, with axons from different parts of the cochlea rolling into the tubular 
nerve, making tonotopic targeting an additional challenge.
6. Current research
With the CI field involving a wide range of professionals including, surgeons, 
nurses, audiologists, engineers, physicists, speech and language therapists, teachers of 
the deaf, hearing therapists, rehabilitation specialists, psychologists and health econo-
mists, research related to the field can cover a very wide range. Here some of the key 
topics that are most closely connected to extending current practice will be reviewed.
It is clear that when less trauma is inflicted during surgery that outcomes are 
better [60], this being the case whether or not there is residual hearing at risk 
[61, 62]. Hearing preservation is thus a key topic for surgeons. The design of less 
traumatic electrode arrays [48–50, 63] and the development of less traumatic 
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surgical techniques [64], including the use of robot assisted insertion [65], are 
factors that can lead to reduced trauma. Providing real time feedback to the surgeon 
during electrode array insertion is a hotly researched area. Electrocochleography 
(ECochG), where acoustic stimulation of the ear produces a cochlear microphonic 
signal [66–68] that the surgeon can use to gauge proximity to structures, such as the 
basilar membrane, appears promising with clinical systems due to launch in 2019.
The use of drugs to reduce the body’s reaction to implantation is also an area 
with some connection to minimizing trauma. Steroids such as Dexamethasone or 
antimitotic drugs [69] have been applied to suppress a fibrotic reaction during and 
immediately after surgery. Some longer term benefits have been shown but mainly 
in lower electrode contact impedances rather than significant outcome advantage 
[70]. Longer term deployment of steroids and other drugs has been proposed for 
some time [71] but has not yet seen clinical practice. Drugs such as neurotrophins 
[72] have been proposed to enhance the spiral ganglion but carry considerable risk 
of uncontrolled sprouting of new fibers that may not lead to any improvement in 
electrical stimulation [73]. Likewise the regrowth of hair cells or other cochlear 
structures [74] is an extremely challenging problem, although simply reconnecting 
peripheral processes that have been damaged while leaving intact hair cells [75] 
may be more manageable in the foreseeable future. While not a drug, near infrared 
light has been shown to promote tissue healing [76], helping reduce the extent of 
hearing loss following cochlear stress [77] and has been proposed as an approach 
that might also enhance the cochlea’s ability to survive the traumas of electrode 
array insertion.
Deployment, development and assessment of sound coding strategies continues 
with a variety of goals. Optimizing compression parameters to maximize speech 
understanding [78], reviewing the effect of various parameters as well as individual-
ized fitting approaches [79, 80] all promise improvements for strategies that are 
already available but could be fitted better. Likewise, tools to guide clinicians in 
fitting for performance, rather than simply for comfort [45] should also lead to sub-
stantial improvement in outcomes. Seeking improvement via limiting current spread, 
through tripolar stimulation [81, 82], phased array [83] or manipulation of field 
interactions [84] have so far not shown a general improvement, although benefits for 
some recipients have been demonstrated. New sound coding strategies that attempt 
to improve temporal information such as FSP [85], or reduce masking effects such as 
MP3000 [31] have been developed and introduced into clinical practice. There may 
be more benefit in reducing battery power from the likes of MP3000 or Optima than 
in any improvement in outcome. Connected to improving outcome, research into the 
listening effort required to understand speech has been increasing [86, 87].
The very nature of the speech tests used to evaluate CI systems is an active area 
of research. Standardization across languages has involved the use of matrix tests 
[88]. These tests involve a fixed syntax and a closed set of keywords so can be self-
administered and used essentially indefinitely. However, the sentences are not fully 
representative of natural sentences. Avoiding fixed presentation levels, something 
necessary to evaluate the function of AGC has led to development of roving presen-
tation level tests [89–91]. These tests provide insights into where a particular subject 
may have problems, so could be useful in supporting programming. As with the 
STARR tests, multiple speakers have been included in tests such as the AzBio [92] 
and taken much further with the coordinate response matrix test that can run on a 
multiple loudspeaker array and hence mimic a more realistic test environment [93].
Improved outcomes have been shown thorough use of the recently developed 
wireless technology supporting integrated bimodal [94, 95] and CROS [96]. EAS 
has also been shown to produce substantial improvements in outcome [97] although 
the test methodology used involves a questionable comparison of conditions.
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With increasing numbers of CI recipients needing management by financially 
constrained health care systems, methods of improving patient management are 
being developed. These include the use of consumer devices, smart phones and 
tablets, to run Apps that can evaluate a CI user’s speech understanding and qualita-
tive condition as well as remotely analyzing the status of their implant and sound 
processor hardware [98] and delivering rehabilitation material usable by adult CI 
recipients and the families of young children. This whole area will necessarily see 
much development in the coming years.
The pressures on CI manufacturers to reduce size and improve comfort and 
ease of use continue, with cosmetic considerations playing a large role in the choice 
of which CI systems are selected. Reliability of both the implanted and external 
parts of the CI system needs to be continuously improved, underpinning consistent 
device use and reducing costs inherent in managing failures. Further pressures 
on cost are also critical to address so that the enormous unmet need for cochlear 
implants in developing countries can also be met.
Glossary of technical terms
Alternate-subtraction a method of removing stimulus artifact that relies on   
 delivering alternate phase stimulation pulses that    
 are added to ideally cancel artifact and reinforce response
Anodic  refers to the positive going phase of a stimulation pulse   
 that is generally assumed to provide change balance, hence  
 avoiding the delivery of potentially harmful direct current
Automatic Gain 
Control (AGC)  
a circuit that compresses the large acoustic dynamic range  
into a range that is more manageable for the restricted   
 electrical dynamic range
Capacitor  an electrical component that does not allow direct current   
 to pass so offers an additional level of protection    
 to the body in the case of a fault occurring in an implant
Cathodic  refers to the negative going phase of a stimulation pulse   
 that is generally assumed to depolarize neurones    
 hence leading to electrical stimulation
Charge  an electrical measure formed by the product (strictly the   
 integral) of current and time with units of Coulombs. The   
 charge delivered determines the loudness perceived
Cochlear Implant (CI) a surgically implantable prosthesis that bypasses a dam-
aged cochlea providing hearing through direct electrical  
stimulation of the auditory nerve
Current source  an electrical circuit that delivers a programmed current,   
 varying the amount of voltage necessary to achieve this   
 depending on the electrical resistance offered by the body
Direct current  an electrical current that flows in one direction only that   
 can be harmful to the body
Electrocochleography 
(ECochG)  
the measurement of electrical signals produced by the   
 cochlea in response to acoustic stimulation that indicates   
 cochlear health
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Electrolysis  an electro-chemical process whereby charged particles   
 may be drawn towards an electrode with opposite charge,   
 leading to electrode contact dissolution or tissue damage
Fast Fourier 
Transform (FFT) 
an efficient software algorithm that evaluates the amount   
 of sound energy at regularly spaced frequencies, so allows   
 the channels to be calculated
Impedance  a measure of resistance to the flow of electrical current   
 that takes account of frequency so is more general   
 than resistance which strictly only applies to direct current
Masker-Probe  a method of stimulus artifact removal relying on introducing 
 refraction to identify artifact and then using multiple   
 stages of subtraction to isolate the neural response
Perilymph  a fluid contained within much of the cochlea that is   
 electrically conductive
Resistance  a measure of how much the body will resist the flow of   
 electrical current, strictly only considering direct current,   
 impedance being the a more general factor
Spiral Ganglion Cell the name given to hearing nerve neurones having a cell   
 body in the cochlea’s modiolus, axon in the auditory nerve   
 and dendrites innervating the inner hair cells
Voltage source  an electrical circuit that delivers a programmed voltage but  
 that will allow current to vary depending on the resistance  
 (impedance) offered by the body
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